Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2008 February;56(1) > Minerva Cardioangiologica 2008 February;56(1):43-53





A Journal on Heart and Vascular Diseases

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752




Minerva Cardioangiologica 2008 February;56(1):43-53

language: English

Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents

Kirtane A. J. 1, Chieffo A. 2, Magni V. 2, Mehran R. 1, Colombo A. 2, Moses J. W. 1

1 Center for Interventional Vascular Therapy Columbia University Medical Center Cardiovascular Research Foundation New York, NY, USA
2 San Raffaele Hospital, Milan, Italy


The percutaneous revascularization of left main coronary artery stenosis has until recently been reserved for patients at prohibitive surgical risk or for selected emergent cases. This adopted practice of coronary artery bypass grafting, as the standard of care for left main coronary artery stenosis, has largely occurred secondary to disappointing results with bare metal stents implanted in the left main coronary artery. However, in the current era of drug-eluting stents (DES) which significantly reduce restenosis compared to bare metal stents, there has been a renewed interest in examining the role of percutaneous coronary intervention as a means of revascularization of left main disease. This article discusses recent and ongoing studies investigating the role of percutaneous intervention of left main disease, with an emphasis on the use of DES for this purpose.

top of page

Publication History

Cite this article as

Corresponding author e-mail